Evaluating the Utility of Intralipid Infusion to Improve Live Birth Rates in Patients with Recurrent Pregnancy Loss or Recurrent Implantation Failure

CONTEXT: Intralipid is used to improve clinical outcomes in patients with recurrent pregnancy loss (RPL) or recurrent implantation failure (RIF) with elevated natural killer (NK) cells. Data supporting this practice is conflicting but suggestive of minimal benefit. AIMS: The aims of this study are t...

Descripción completa

Detalles Bibliográficos
Autores principales: Martini, Anne E., Jasulaitis, Sue, Fogg, Louis F., Uhler, Meike L., Hirshfeld-Cytron, Jennifer E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262661/
https://www.ncbi.nlm.nih.gov/pubmed/30568356
http://dx.doi.org/10.4103/jhrs.JHRS_28_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262661/
https://www.ncbi.nlm.nih.gov/pubmed/30568356
http://dx.doi.org/10.4103/jhrs.JHRS_28_18

Ejemplares similares